Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 9

1.

Statins and the risk of hepatocellular carcinoma in patients with hepatitis B virus infection.

Tsan YT, Lee CH, Wang JD, Chen PC.

J Clin Oncol. 2012 Feb 20;30(6):623-30. doi: 10.1200/JCO.2011.36.0917. Erratum in: J Clin Oncol. 2013 Aug 20;31(24):3049.

PMID:
22271485
2.

Chemopreventive strategies in hepatocellular carcinoma.

Singh S, Singh PP, Roberts LR, Sanchez W.

Nat Rev Gastroenterol Hepatol. 2014 Jan;11(1):45-54. doi: 10.1038/nrgastro.2013.143. Review.

3.

Statins are associated with a reduced risk of hepatocellular cancer: a systematic review and meta-analysis.

Singh S, Singh PP, Singh AG, Murad MH, Sanchez W.

Gastroenterology. 2013 Feb;144(2):323-32. doi: 10.1053/j.gastro.2012.10.005. Review.

PMID:
23063971
4.

Natural history of chronic hepatitis B REVEALed.

Chen CJ, Yang HI.

J Gastroenterol Hepatol. 2011 Apr;26(4):628-38. doi: 10.1111/j.1440-1746.2011.06695.x. Review.

PMID:
21323729
5.

Hepatocellular carcinoma in cirrhosis: incidence and risk factors.

Fattovich G, Stroffolini T, Zagni I, Donato F.

Gastroenterology. 2004 Nov;127(5 Suppl 1):S35-50. Review.

PMID:
15508101
6.

Perspectives and control of hepatitis B virus infection in Taiwan.

Lin CL, Kao JH.

J Formos Med Assoc. 2015 Oct;114(10):901-9. doi: 10.1016/j.jfma.2015.06.003. Review.

7.

What can we learn from hepatitis B virus clinical cohorts?

Lin CL, Tseng TC, Kao JH.

Liver Int. 2015 Jan;35 Suppl 1:91-9. doi: 10.1111/liv.12716. Review.

PMID:
25529093
8.

[Hepatocellular carcinoma, hepatitis B virus and the immune system].

Grob PJ.

Schweiz Med Wochenschr. 1986 Aug 23;116(34):1133-45. Review. German.

PMID:
3020684
9.

The epidemiology and prevention of hepatocellular carcinoma.

Monto A, Wright TL.

Semin Oncol. 2001 Oct;28(5):441-9. Review.

PMID:
11685737

Supplemental Content

Support Center